Gattex is a Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Shire-nps Pharmaceuticals, Inc.. The primary component is Teduglutide.
Product ID | 68875-0101_008b6d52-ee4e-466e-a4be-8f3ce9b4bdcb |
NDC | 68875-0101 |
Product Type | Human Prescription Drug |
Proprietary Name | Gattex |
Generic Name | Teduglutide |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2012-12-21 |
Marketing Category | NDA / NDA |
Application Number | NDA203441 |
Labeler Name | Shire-NPS Pharmaceuticals, Inc. |
Substance Name | TEDUGLUTIDE |
Active Ingredient Strength | 5 mg/.5mL |
Pharm Classes | GLP-2 Analog [EPC],Glucagon-like Peptide-2 (GLP-2) Agonists [MoA],Glucagon-Like Peptide 2 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2012-12-21 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA203441 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-12-21 |
Marketing End Date | 2013-01-16 |
Marketing Category | NDA |
Application Number | NDA203441 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-01-16 |
Marketing Category | NDA |
Application Number | NDA203441 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-12-21 |
Ingredient | Strength |
---|---|
TEDUGLUTIDE | 5 mg/.5mL |
SPL SET ID: | 66b69c1e-b25c-44d3-b5ff-1c1de9a516fa |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
68875-0101 | Gattex | teduglutide |
68875-0102 | Gattex | teduglutide |
68875-0103 | Gattex | teduglutide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
GATTEX 85731454 4475896 Live/Registered |
SHIRE-NPS PHARMACEUTICALS, INC. 2012-09-18 |
GATTEX 78333286 3406472 Live/Registered |
SHIRE-NPS PHARMACEUTICALS, INC. 2003-11-25 |